Showing results 1 to 20 of 21
next >
| Issue Date | Title | Author(s) |
| 17-Jul-2019 | A pooled analysis of the duration of chemoprophylaxis against malaria after treatment with artesunate-amodiaquine and artemether-lumefantrine: data & analysis output | Bretscher, M; Dahal, P; Griffin, J; Stepniewska, K; Bassat, Q, et al |
| 31-Aug-2016 | Alternative molecular methods for improved detection of meningococcal carriage and measurement of bacterial density | Manigart, O; Okeakpu, J; Odutola, A; Jarju, S; Foster-Nyarko, E, et al |
| 1-Nov-2014 | Contrasting benefits of different artemisinin combination therapies as first-line malaria treatments using model-based cost-effectiveness analysis | Okell, LC; Cairns, M; Griffin, JT; Ferguson, NM; Tarning, J, et al |
| 1-May-2018 | Detection, characterization, and enrollment of donors of Ebola convalescent plasma in Sierra Leone | Tedder, RS; Samuel, D; Dicks, S; Scott, JT; Ijaz, S, et al |
| Oct-2018 | Development of a simple score based on HBeAg and ALT for selecting patients for HBV treatment in Africa | Yusuke, S; Njie, R; Ndow, G; Vray, M; Mbaye, PS, et al |
| 27-Aug-2019 | Field performance of the malaria highly sensitive rapid diagnostic test in a setting of varying malaria transmission | Mwesigwa, J; Slater, H; Bradley, J; Saidy, B; Ceesay, F, et al |
| 1-Apr-2020 | Hepatitis B core-related antigen (HBcrAg): an alternative to HBV DNA to assess treatment eligibility in Africa | Shimakawa, Y; Ndow, G; Njie, R; Njai, HF; Takahashi, K, et al |
| 10-Jul-2020 | Hepatitis B virus preS2 Delta 38-55 variants: A newly identified risk factor for hepatocellular carcinoma | Cohen, D; Ghosh, S; Shimakawa, Y; Ramou, N; Garcia, PS, et al |
| Apr-2020 | Ivermectin as a novel complementary malaria control tool to reduce incidence and prevalence: a modelling study | Slater, HC; Foy, BD; Kobylinski, K; Chaccour, C; Watson, OJ, et al |
| 24-Feb-2011 | Likely Health Outcomes for Untreated Acute Febrile Illness in the Tropics in Decision and Economic Models; A Delphi Survey | Lubell, Y; Staedke, SG; Greenwood, BM; Kamya, MR; Molyneux, M, et al |
| 9-Dec-2021 | Malaria protection due to sickle haemoglobin depends on parasite genotype | Band, G; Leffler, EM; Jallow, M; Sisay-Joof, F; Ndila, CM, et al |
| 17-Jun-2019 | Modelling pathogen load dynamics to elucidate mechanistic determinants of host-Plasmodium falciparum interactions | Georgiadou, A; Lee, HJ; Walther, M; Van Beek, A; Fitriani, F, et al |
| 1-Dec-2016 | Natural history of chronic HBV infection in West Africa: a longitudinal population-based study from The Gambia | Shimakawa, Y; Lemoine, M; Njai, HF; Bottomley, C; Ndow, G, et al |
| 1-Sep-2022 | Prevalence and clinical significance of occult hepatitis B infection in The Gambia, West Africa. | Ndow, G; Cessay, A; Cohen, D; Shimakawa, Y; Gore, ML, et al |
| 1-May-2019 | Prevention of liver fibrosis and liver cancer linked to hepatitis B virus in Africa: the Prolifica study | Cohen, D; Shimakawa, Y; Ndow, G; Sow, A; Tamba, S, et al |
| 22-Oct-2015 | Serology describes a profile of declining malaria transmission in Farafenni, The Gambia | Van den Hoogen, LL; Griffin, JT; Cook, J; Sepúlveda, N; Corran, P, et al |
| 25-Feb-2020 | The duration of chemoprophylaxis against malaria after treatment with artesunate-amodiaquine and artemether-lumefantrine and the effects of pfmdr1 86Y and pfcrt 76T: a meta-analysis of individual patient data | Okell, L; Bretscher, MT; Dahal, P; Griffin, J; Stepniewska, K, et al |
| 3-Nov-2016 | The emerging threat of pre-extensively drug-resistant tuberculosis in West Africa: preparing for large-scale tuberculosis research and drug resistance surveillance | Gehre, F; Otu, J; Kendall, L; Forson, A; Kwara, A, et al |
| 8-Jul-2016 | The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa | Lemoine, M; Shimakawa, Y; Nayagam, S; Khalil, M; Suso, P, et al |
| 3-Jun-2016 | The RooPfs study to assess whether improved housing provides additional protection against clinical malaria over current best practice in The Gambia: study protocol for a randomized controlled study and ancillary studies | Pinder, M; Conteh, L; Jeffries, D; Jones, C; Knudsen, J, et al |